Frontiers in Drug Design & Discovery

Frontiers in Drug Design & Discovery

Volume: 8

Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Cancer Chemotherapy: Recent Developments in Hematology Oncology

Pp. 1-51 (51)

Sapna Parmar, Rebecca Nelson and Erica Hochard

Abstract

Research specialized in the field of hematology oncology over relatively recent years has revolutionized patient care and led to an array of chemotherapeutic agents approved by the Food and Drug Administration. Both oral and intravenous drug formulations have been marketed, including targeted therapies, for several hematologic disorders including acute and chronic leukemias, Hodgkin and non-Hodgkin’s lymphomas, multiple myeloma, and myelofibrosis. The primary focus of this chapter will include latest chemotherapy developments in hematology covering critical topics of pharmacology, pharmacokinetics/pharmacodynamics, and pivotal clinical studies addressing both labeled and off-labeled indications. Lastly, future directions will be addressed, where applicable, in this continuously evolving clinical field.

Keywords:

Acute lymphoblastic leukemia, Anaplastic large cell lymphoma, Bone marrow transplant, Cancer, Chemotherapy, Chronic lymphocytic leukemia, Chronic myeloid leukemia, Hematology, Hodgkin lymphoma, Mantle cell lymphoma, Multiple myeloma, Myelofibrosis, Non-Hodgkin’s lymphoma, Oncology, T-cell lymphoma.

Affiliation:

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, USA